共 50 条
- [41] Correction to: Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial ProgramAmerican Journal of Clinical Dermatology, 2021, 22 : 905 - 905Eric L. SimpsonJonathan I. SilverbergAudrey NosbaumKevin L. WinthropEmma Guttman-YasskyKarin M. HoffmeisterAlexander EgebergHernan ValdezMin ZhangSaleem A. FarooquiWilliam RomeroAndrew J. ThorpeRicardo RojoSusan Johnson
- [42] Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: A pooled analysis from two controlled phase III clinical studiesINTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (05) : 363 - 368Knopp, RHDujovne, CALe Beaut, ALipka, LJSuresh, RVeltri, EP
- [43] RETROSPECTIVE ANALYSIS OF TWO CLINICAL STAGING SYSTEMS FOR AMYOTROPHIC LATERAL SCLEROSIS (ALS) USING DATA FROM A PHASE III TRIAL OF EDARAVONEVALUE IN HEALTH, 2017, 20 (05) : A189 - A189Bornheimer, R.Dukes, E. M.Agnese, W.Merrill, C.Oster, G.
- [44] The WATER study clinical results - a subgroup analysis of larger prostates from the Phase III blinded randomized trial of Aquablation versus TURPBJU INTERNATIONAL, 2018, 121 : 12 - 12Roehrborn, C.Anderson, P.Gilling, P.
- [45] Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasisJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (01) : 83 - +van de Kerkhof, Peter C. M.Griffiths, Christopher E. M.Reich, KristianLeonardi, Craig L.Blauvelt, AndrewTsai, Tsen-FangGong, YankunHuang, JiaqingPapavassilis, CharisFox, Todd
- [46] Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trialInvestigational New Drugs, 2018, 36 : 476 - 486Emiliano CalvoAnalia AzaroJordi RodonLuc DirixManon HuizingFrancis Mark SenecalPatricia LoRussoLorrin YeeItalo PoggesiJan de JongSpyros TriantosYoun C. ParkRoland E. KnoblauchTrilok V. ParekhGeorge D. DemetriMargaret von Mehren
- [47] Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trialINVESTIGATIONAL NEW DRUGS, 2018, 36 (03) : 476 - 486Calvo, EmilianoAzaro, AnaliaRodon, JordiDirix, LucHuizing, ManonSenecal, Francis MarkLoRusso, PatriciaYee, LorrinPoggesi, Italode Jong, JanTriantos, SpyrosPark, Youn C.Knoblauch, Roland E.Parekh, Trilok V.Demetri, George D.von Mehren, Margaret
- [48] Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III StudiesJOURNAL OF RHEUMATOLOGY, 2018, 45 (02) : 177 - 187Charles-Schoeman, Christinavan der Heijde, DesireeBurmester, Gerd R.Nash, PeterZerbini, Cristiano A. F.Connell, Carol A.Fan, HaiyunKwok, KennethBananis, EustratiosFleischmann, Roy
- [49] Clinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis:: results from a phase III international randomized, placebo-controlled trialBRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (01) : 170 - 181Dubertret, L.Sterry, W.Bos, J. D.Chimenti, S.Shumack, S.Larsen, C. G.Shear, N. H.Papp, K. A.
- [50] Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trialLANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 34Chu, KaiBi, Zhao-FengHuang, Wei-JinLi, Ya-FeiZhang, LiYang, Chang-LinJiang, Han -MinZang, XiaChen, QiLiu, Dong-LinPan, Hong-XingHuang, YueZheng, Feng-ZhuZhang, Qiu-FenSun, GuangSu, Ying-YingHuang, Shou-JiePan, Hui-RongWu, TingHu, Yue-MeiZhang, JunZhu, Feng-CaiXia, Ning-Shao